Supplementary Figure 3 from Reducing TNF Receptor 2&lt;sup&gt;+&lt;/sup&gt; Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients